CABG With Internal Thoracic Artery in Children With Congenital Heart Defects: A Good Option When It Is the Only One

Christian Kreutzer1, Gustavo Bastianelli2, Benjamin Chiostri1

  • 1Division of Pediatric Cardiovascular Surgery, 218809Hospital Universitario Austral. Pilar, Buenos Aires, Argentina.

Insights

Coronary artery bypass grafting (CABG) using internal thoracic artery (ITA) grafts is a valuable option for children with complex congenital heart defects. All patients in this study showed successful graft patency and remained asymptomatic, highlighting the long-term viability of arterial grafts in pediatric cardiac surgery.

Area of Science:

  • Pediatric Cardiac Surgery
  • Congenital Heart Disease
  • Vascular Grafting

Background:

  • Coronary artery complications are a known risk during and after congenital heart defect repairs.
  • Complex coronary anatomy in pediatric patients often necessitates specialized surgical interventions beyond standard repairs.

Observation:

  • This study retrospectively reviewed four pediatric cases undergoing coronary artery bypass grafting (CABG) with internal thoracic artery (ITA) grafts between March 2016 and March 2020.
  • Patients presented with diverse congenital anomalies including anomalous coronary artery origin, post-arterial switch hypoplasia, and coronary stenosis after previous procedures.
  • Surgical interventions involved various ITA graft configurations to address specific coronary artery issues, often combined with other cardiac repair procedures.

Findings:

  • All four patients were asymptomatic at the last follow-up, demonstrating successful management of coronary complications.
  • Ventricular function remained normal in all patients post-operatively.
  • All internal thoracic artery grafts were patent, indicating excellent long-term graft viability in this pediatric cohort.

Implications:

  • Coronary artery bypass grafting (CABG) with arterial grafts like the internal thoracic artery (ITA) is a crucial alternative for complex pediatric coronary anomalies.
  • The long-term patency observed in this study supports the mandatory use of arterial grafts for pediatric patients requiring grafts with a >50-year lifespan.
  • This approach offers a viable solution for improving long-term outcomes in children with challenging congenital heart disease and associated coronary issues.
Abstract